Literature DB >> 25805585

The histological classification of diffuse large B-cell lymphomas.

Yi Xie1, Stefania Pittaluga1, Elaine S Jaffe2.   

Abstract

Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, biologic, and pathologic diversity, in part reflecting the functional diversity of the B-cell system and multiple pathways of transformation. In recent years, the advent of new high-throughput genomic technologies has provided new insights into the biology of DLBCL, leading to the identification of distinct molecular identities and novel pathogenetic pathways. This increasing complexity had led to an expanding number of entities in the World Health Organization classification. Using a multi-modality approach, the updated 2008 classification delineated some new subgroups, including DLBCLs associated with particular age groups or specific anatomic sites, as well as two borderline categories (tumors at the interface between classical Hodgkin lymphoma and DLBCL as well as between Burkitt lymphoma and DLBCL). This article reviews the histopathologic features of the various aggressive B-cell lymphoma subtypes included in the 2008 classification, with emphasis on some of the new entities as well as areas of diagnostic challenge. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25805585      PMCID: PMC4374126          DOI: 10.1053/j.seminhematol.2015.01.006

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  88 in total

1.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

2.  Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients.

Authors:  H Narimatsu; Y Ota; M Kami; K Takeuchi; R Suzuki; K Matsuo; T Matsumura; K Yuji; Y Kishi; T Hamaki; U Sawada; S Miyata; T Sasaki; K Tobinai; M Kawabata; Y Atsuta; Y Tanaka; R Ueda; S Nakamura
Journal:  Ann Oncol       Date:  2006-10-16       Impact factor: 32.976

3.  Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

Authors:  Michael R Green; Stefano Monti; Scott J Rodig; Przemyslaw Juszczynski; Treeve Currie; Evan O'Donnell; Bjoern Chapuy; Kunihiko Takeyama; Donna Neuberg; Todd R Golub; Jeffery L Kutok; Margaret A Shipp
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

4.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

5.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

6.  Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.

Authors:  Camille Laurent; Catherine Do; Randy D Gascoyne; Laurence Lamant; Loïc Ysebaert; Guy Laurent; Georges Delsol; Pierre Brousset
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

7.  Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

Authors:  Takashi Oyama; Kazuhito Yamamoto; Naoko Asano; Aya Oshiro; Ritsuro Suzuki; Yoshitoyo Kagami; Yasuo Morishima; Kengo Takeuchi; Toshiyuki Izumo; Shigeo Mori; Koichi Ohshima; Junji Suzumiya; Naoya Nakamura; Masafumi Abe; Koichi Ichimura; Yumiko Sato; Tadashi Yoshino; Tomoki Naoe; Yoshie Shimoyama; Yoshikazu Kamiya; Tomohiro Kinoshita; Shigeo Nakamura
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

8.  Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios.

Authors:  Florence Loong; Alexander C L Chan; Bernard C S Ho; Yuk-Ping Chau; Hwei-Yee Lee; Wah Cheuk; Wai-Key Yuen; Wing-Shun Ng; Hung-Leong Cheung; John K C Chan
Journal:  Mod Pathol       Date:  2010-01-08       Impact factor: 7.842

9.  Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Nathalie A Johnson; Graham W Slack; Kerry J Savage; Joseph M Connors; Susana Ben-Neriah; Sanja Rogic; David W Scott; King L Tan; Christian Steidl; Laurie H Sehn; Wing C Chan; Javeed Iqbal; Paul N Meyer; Georg Lenz; George Wright; Lisa M Rimsza; Carlo Valentino; Patrick Brunhoeber; Thomas M Grogan; Rita M Braziel; James R Cook; Raymond R Tubbs; Dennis D Weisenburger; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Christina Holcroft; Elaine S Jaffe; Louis M Staudt; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

10.  Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

Authors:  Lluís Colomo; Florence Loong; Susana Rives; Stefania Pittaluga; Antonio Martínez; Armando López-Guillermo; Jesús Ojanguren; Vicens Romagosa; Elaine S Jaffe; Elías Campo
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

View more
  19 in total

Review 1.  Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.

Authors:  Grzegorz S Nowakowski; Kristie A Blum; Brad S Kahl; Jonathan W Friedberg; Lawrence Baizer; Richard F Little; David G Maloney; Laurie H Sehn; Michael E Williams; Wyndham H Wilson; John P Leonard; Sonali M Smith
Journal:  J Natl Cancer Inst       Date:  2016-12-16       Impact factor: 13.506

Review 2.  Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.

Authors:  Xueyi Zheng; Yuhua Huang; Kai Li; Rongzhen Luo; Muyan Cai; Jingping Yun
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

3.  The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Authors:  Leandro Venturutti; Ari M Melnick
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

4.  Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas.

Authors:  Nour Ghazzaui; Hussein Issaoui; Mélissa Ferrad; Claire Carrion; Jeanne Cook-Moreau; Yves Denizot; François Boyer
Journal:  Blood Adv       Date:  2020-01-14

5.  Therapeutic vaccines for aggressive B-cell lymphoma.

Authors:  Zijun Y Xu-Monette; Ken H Young
Journal:  Leuk Lymphoma       Date:  2020-08-25

Review 6.  DNA methyltransferases in hematological malignancies.

Authors:  Nguyet-Minh Hoang; Lixin Rui
Journal:  J Genet Genomics       Date:  2020-07-24       Impact factor: 4.275

Review 7.  Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?

Authors:  Amit Dipak Amin; Tara L Peters; Lingxiao Li; Soumya Sundara Rajan; Ramesh Choudhari; Soham D Puvvada; Jonathan H Schatz
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-05

Review 8.  Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.

Authors:  Shu-Mei Zheng; De-Jiang Zhou; Yi-Hua Chen; Rui Jiang; Yun-Xia Wang; Yong Zhang; Hong-Li Xue; Hai-Qiong Wang; Dong Mou; Wei-Zheng Zeng
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

Review 9.  The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives.

Authors:  Lina Elsalem; Ahmad A Jum'ah; Mahmoud A Alfaqih; Osama Aloudat
Journal:  Clin Exp Gastroenterol       Date:  2020-05-06

Review 10.  Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma.

Authors:  Grzegorz S Nowakowski; Tatyana Feldman; Lisa M Rimsza; Jason R Westin; Thomas E Witzig; Pier Luigi Zinzani
Journal:  Blood Cancer J       Date:  2019-05-16       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.